Data Factory
Reading the graph
Reading the graph
Venture Capital
Palo Alto, CA
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Asset Management Ventures V, L.P. | 2020 | Mature | $32.5M | $14.0M | 0 |
| Asset Management Ventures IV, L.P. | 2015 | Harvest | $25.2M | $34.9M | 0 |
| Asset Management Ventures Fund, L.P. | 2013 | Harvest | $0 | $194M | 0 |
| Asset Management Partners 2004, L.P. | 2004 | Harvest | n/a | $2.0M | 0 |
| Asset Management Company Venture Fund, L.P. | n/a | Unknown | n/a | $52.0M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| 1DocWay | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| 3T Biosciences | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Aavia | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Amgen | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Amygdala Neurosciences | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Array Insights | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Arterys | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Audentes Therapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Autonomize, Inc. | TX | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| basys | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Benefitter | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Biogen Idec | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| BiPar Sciences | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Carta Healthcare | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| CV Therapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Decent | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Endless Health Inc. | TX | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Esperion Therapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Evidation Health | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Freenome | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| HealthTap | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Incardatherapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Indi Molecular | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| KeepSafe | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Kii | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Asset Management Ventures, LLC | Menlo Ventures | 3 | 3 | Sep 16, 2026 | Recurring |
| Dorm Room Fund | Asset Management Ventures, LLC | 2 | 2 | Sep 16, 2026 | Recurring |
| Asset Management Ventures, LLC | Healthy Ventures Management, LLC | 2 | 2 | Sep 16, 2026 | Recurring |
| Asset Management Ventures, LLC | Windham Venture Partners | 2 | 2 | Sep 16, 2026 | Recurring |
| Asset Management Ventures, LLC | Artis Ventures Management, L.P. | 2 | 2 | Sep 16, 2026 | Recurring |
| Asset Management Ventures, LLC | CRV, LLC | 2 | 2 | Sep 16, 2026 | Recurring |
| Asset Management Ventures, LLC | Canaan Partners | 2 | 2 | Sep 16, 2026 | Recurring |
| Asset Management Ventures, LLC | Artis Capital Management, L.P. | 2 | 2 | Sep 16, 2026 | Recurring |
| Asset Management Ventures, LLC | Great Oaks Management Company LLC | 1 | 1 | Sep 16, 2026 | One time |
| Asset Management Ventures, LLC | Innovation Endeavors: Reimagining the technical frontier | 1 | 1 | Sep 16, 2026 | One time |
| Asset Management Ventures, LLC | Merck Global Health Innovation Fund | 1 | 1 | Sep 19, 2026 | One time |
| Asset Management Ventures, LLC | Differential Venture Partners, LLC | 1 | 1 | Sep 16, 2026 | One time |
| Asset Management Ventures, LLC | Catalio Capital Management, LP | 1 | 1 | Sep 16, 2026 | One time |
| Asset Management Ventures, LLC | Sierra Ventures | 1 | 1 | Sep 16, 2026 | One time |
| Asset Management Ventures, LLC | Rethink Capital Partners, LLC | 1 | 1 | Sep 16, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Skip Fleshman (Partner), Nemariam Mesfin (Chief Financial Officer), David G Fleshman (Managing Member), Richard T Simoni (Managing Member), Louis Lange (Managing Member).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan